Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000350692

Medchemexpress LLC MKI-1 (MASTL Kinase Inhibitor-1) | 1190277-80-5 | 98.1% | 302.33 | 100 MG
SDP

Catalog No. 5000350692
Encompass_Preferred

MKI-1 is a novel small-molecule inhibitor of MASTL (microtubule-associated serine/threonine kinase-like) with an IC50 of 9.9 μM. It demonstrates antitumor and radiosensitizer activities by activating PP2A in breast cancer.

  • Inhibits MASTL activity.
  • Suppresses various oncogenic properties in cancer cells.
  • Reduces both serine 62-phosphorylation and total c-Myc, alongside a decrease in ENSA phosphorylation.
  • Decreases c-Myc stability through PP2A activation.
  • Reduces tumor growth and enhances radiosensitivity in xenograft models.
  • Exhibits low gross toxicity in treated animal models, with no notable changes in body weight.

Catalog No. 50-003-50692 Supplier Medchemexpress LLC Supplier No. HY137552100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

MKI-1 is a novel small-molecule inhibitor of MASTL (microtubule-associated serine/threonine kinase-like) with an IC50 of 9.9 μM. It demonstrates antitumor and radiosensitizer activities by activating PP2A in breast cancer.

  • Inhibits MASTL activity.
  • Suppresses various oncogenic properties in cancer cells.
  • Reduces both serine 62-phosphorylation and total c-Myc, alongside a decrease in ENSA phosphorylation.
  • Decreases c-Myc stability through PP2A activation.
  • Reduces tumor growth and enhances radiosensitivity in xenograft models.
  • Exhibits low gross toxicity in treated animal models, with no notable changes in body weight.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.